Friday, February 8, 2013 Thursday, February 7, 2013- No Sign of a Slowdown at This Recession Resistant Companyat Motley Fool (Thu, Feb 7)
- Analyst Moves: AGN, BIIBat Forbes (Thu, Feb 7)
- Allergan Target Raised and 4 Stock Analyses Making Roundsat Wall St. Cheat Sheet (Thu, Feb 7)
- Allergan Earnings Call Nuggets: DARPin and RESTASISat Wall St. Cheat Sheet (Thu, Feb 7)
- Allergan, Inc. and MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early Termination of Waiting Period Under Hart-Scott-Rodino ActBusiness Wire (Thu, Feb 7)
- Allergan price target raised to $118 from $104 at Argustheflyonthewall.com (Thu, Feb 7)
- Allergan price target raised to $124 from $106 at Citigrouptheflyonthewall.com (Thu, Feb 7)
Wednesday, February 6, 2013 Tuesday, February 5, 2013- Allergan Meets on the Top Line, Misses Where it Countsat Motley Fool (Tue, Feb 5)
- Cramer's 'Mad Money' Recap: Follow the Big Moneyat TheStreet (Tue, Feb 5)
- [video] AGN CEO Talks Earningsat CNBC (Tue, Feb 5)
- Favorite Growth Pharma Play: Jim Cramerat CNBC (Tue, Feb 5)
- Allergan Reports Mixed Q4, But Bullish Margin Outlookat Investor's Business Daily (Tue, Feb 5)
- January Top 10: MAP Pharmaceuticalsat Motley Fool (Tue, Feb 5)
- Allergan Seeks to Sell Lap-Band and Obesity Unit By Juneat Bloomberg (Tue, Feb 5)
- AGN Earnings Miss but Guidance TopsZacks (Tue, Feb 5)
Add AGN News to My Yahoo!  | |
|